Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-02Clinical Trial Update: Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer [NA]
A clinical trial update from Fudan University investigates BRCA1/2 mutations and other potential genes in triple-negative breast cancer, wit…
-
CLINICAL_TRIALS research · 2015-11-03Clinical Trial Update: Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer [Phase 3]
This update describes a Phase 3 trial evaluating zoledronic acid as adjuvant therapy for triple-negative breast cancer. The study is sponsor…
-
CLINICAL_TRIALS research · 2015-09-09Clinical Trial Update: Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients [Phase 2]
This is a completed Phase 2 study evaluating apatinib in patients with metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS research · 2015-07-22Clinical Trial Update: Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
This update notes the completed clinical trial evaluating chemotherapy with DC-CIK cell-based adoptive cellular therapy in triple-negative b…
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer [NA]
This document provides an update on a clinical trial studying breast-conserving therapy for patients with triple-negative breast cancer; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-18Clinical Trial Update: Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
This clinical trial investigates whether tumor suppressor gene status can predict chemotherapy response in triple-negative breast cancer.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
This document reports on a clinical trial evaluating metronomic capecitabine after standard adjuvant chemotherapy in operable triple-negativ…
-
CLINICAL_TRIALS research · 2013-07-23Clinical Trial Update: Triple Negative Breast Cancer Biomarker Study
A completed biomarker-focused clinical trial for metastatic triple-negative breast cancer sponsored by US Oncology Research.
-
CLINICAL_TRIALS research · 2013-01-04Clinical Trial Update: Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. [Phase 2]
This entry describes a Phase 2 clinical trial evaluating preoperative chemotherapy for triple-negative invasive breast cancer that can be re…
-
CLINICAL_TRIALS research · 2012-12-25Clinical Trial Update: A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 3]
Phase III trial evaluating carboplatin as adjuvant chemotherapy for triple-negative breast cancer; current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2011-12-28Clinical Trial Update: The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC [Phase 3]
This clinical trial update describes a Phase 3 study comparing dose-dense AC-T (doxorubicin/cyclophosphamide followed by paclitaxel) with PC…